AMED - アメディシス （Amedisys Inc） アメディシスAMEDのチャート
AMEDの企業情報
| symbol | AMED |
|---|---|
| 会社名 | Amedisys Inc. （アメディシス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Nursing Services |
| 業種 | ヘルスケア施設_サ―ビス 医療関連（Health Care） |
| 概要 | 事業概要 アメディシス(Amedisys Inc)はヘルスケアサービス企業である同社の事業は在宅医療、ホスピス、パーソナルケアおよびその他である。同社は在宅医療、ホスピスおよびパーソナルケアサービスの提供者である。同社の在宅医療事業は患者が手術・病気から回復し、慢性疾患に罹り、病院の再入院の防止をサポートする医療を提供する。ホスピス事業は終末期疾患の患者を支援する。パーソナルケア事業は患者に日常生活の不可欠な活動を支援する。 アメディシスは米国の在宅医療・ホスピスサ―ビスプロバイダ―。在宅医療部門は看護師、ナ―スプラクティショナ―、介護助手、理学療法士、作業療法士、言語療法士、医療ソ―シャルワ―カ―などを通じた在宅医療サ―ビス・プログラムを提供。ホスピス部門は末期患者とその家族に緩和医療を提供。米国とプエルトリコで事業を展開。 Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,900 hospitals and 78,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With ~21,000 employees, in 514 care centers in 39 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 418,000 patients in need every year. |
| 本社所在地 | 3854 American Way Suite A Baton Rouge LA 70816 USA |
| 代表者氏名 | Paul B. Kusserow Paul B. Kusserow |
| 代表者役職名 | President Chief Executive Officer Director 社長兼最高経営責任者（CEO） |
| 電話番号 | +1 225-292-2031 |
| 設立年月日 | 1982年 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 17900人 |
| url | www.amedisys.com |
| nasdaq_url | https://www.nasdaq.com/symbol/amed |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 148.16200 |
| 終値（lastsale） | 116.85 |
| 時価総額（marketcap） | 3720036833.7 |
| 時価総額 | 時価総額（百万ドル） 3784.027 |
| 売上高 | 売上高（百万ドル） 1595.266 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 3882.728 |
| 当期純利益 | 当期純利益（百万ドル） 92.21800 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Amedisys Inc revenues increased 10% to $810.9M. Net income increased from $19.6M to $60.5M. Revenues reflect Home Health Care segment increase of 6% to $575.6M Hospice segment increase of 13% to $198.7M Personal care segment increase of 31% to $36.6M. Net income benefited from Other segment loss decrease of 31% to $65.8M Home Health Care segment income increase of 22% to $86.7M. |
AMEDのテクニカル分析
AMEDのニュース
Amedisys Inc. (NASDAQ:AMED) Shares Surged 7.46% In A Week – But Will They Keep Going Up? 2022/11/26 15:30:00 Marketing Sentinel
In last trading session, Amedisys Inc. (NASDAQ:AMED) saw 0.21 million shares changing hands with its beta currently measuring 0.97. Company’s recent per share price level of $91.04 trading at -$0.21 or -0.23% at ring of the bell on the day assigns it a market valuation of $2.92B. That closing price of AMED’s stock is at … Amedisys Inc. (NASDAQ:AMED) Shares Surged 7.46% In A Week – But Will They Keep Going Up? Read More »
Amedisys names new COO 2022/11/22 22:23:29 Seeking Alpha
Amedisys (AMED) names Scott Ginn, Executive VP and CFO, its acting COO, effective immediately.Ginn has led financial teams since 2007, serving as senior VP of Accounting and Controller…
Amedisys fires CEO, replaces him with former leader | New Orleans CityBusiness 2022/11/18 20:03:13 New Orleans CityBusiness
Baton Rouge-based home health care company Amedisys says it fired CEO Christopher Gerard and replaced him with former CEO Paul Kusserow.
Amedisys Inc. terminates president and CEO, effective immediately 2022/11/18 17:29:17 Business Journals
The company''s chairman will act as interim CEO until a successor is found.
Amedisys fires CEO Gerard 2022/11/18 13:30:00 NashvillePost
Home health and hospice company brings on former leader in interim role
Amedisys Inc. (NASDAQ:AMED) Shares Surged 7.46% In A Week – But Will They Keep Going Up? 2022/11/26 15:30:00 Marketing Sentinel
In last trading session, Amedisys Inc. (NASDAQ:AMED) saw 0.21 million shares changing hands with its beta currently measuring 0.97. Company’s recent per share price level of $91.04 trading at -$0.21 or -0.23% at ring of the bell on the day assigns it a market valuation of $2.92B. That closing price of AMED’s stock is at … Amedisys Inc. (NASDAQ:AMED) Shares Surged 7.46% In A Week – But Will They Keep Going Up? Read More »
Amedisys names new COO 2022/11/22 22:23:29 Seeking Alpha
Amedisys (AMED) names Scott Ginn, Executive VP and CFO, its acting COO, effective immediately.Ginn has led financial teams since 2007, serving as senior VP of Accounting and Controller…
Amedisys fires CEO, replaces him with former leader | New Orleans CityBusiness 2022/11/18 20:03:13 New Orleans CityBusiness
Baton Rouge-based home health care company Amedisys says it fired CEO Christopher Gerard and replaced him with former CEO Paul Kusserow.
Amedisys Inc. terminates president and CEO, effective immediately 2022/11/18 17:29:17 Business Journals
The company''s chairman will act as interim CEO until a successor is found.
Amedisys fires CEO Gerard 2022/11/18 13:30:00 NashvillePost
Home health and hospice company brings on former leader in interim role
Amedisys Announces Second Quarter 2022 Earnings Release and Conference Call Date 2022/07/06 12:00:00 GlobeNewswire
BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the second quarter ended June 30, 2022, after the market closes on July 27, 2022. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on July 28, 2022.
ADUS, AMED stocks given opposing views at Stifel on Medicare rate cuts (NASDAQ:AMED) 2022/06/29 17:42:40 Seeking Alpha
Launching its coverage on Amedisys (AMED) and Addus HomeCare (ADUS), Stifel issues a contrasting view on the two home health care companies after the Centers for Medicare and…
Amedisys stock slumps 13% as Bofa trims rating on CMS proposed Medicare home health rate cut 2022/06/21 16:34:31 Seeking Alpha
Amedisys (AMED) stock fell ~13% on June 21 after Bank of America downgraded the stock to Underperform from Neutral with a price target of $102, from $145, following Centers for Medicare…
Amedisys AMED Technical Pivots with Risk Controls 2022/06/03 05:45:00 Stock Traders Daily
Technical analysis for Amedisys AMED including support levels resistance levels and stop losses for AMED
Analyst Ratings for Amedisys 2022/05/27 18:38:43 Benzinga
Over the past 3 months, 5 analysts have published their opinion on Amedisys (NASDAQ: AMED ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 2 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 1 0 0 According to 5 analyst offering 12-month price targets in the last 3 months, Amedisys has an average price target of $155.6 with a high of $182.00 and a low … Full story available on Benzinga.com